Furanones as potential anti-bacterial coatings on biomaterials

Biomaterials

Volumn 25, Issue 20, 2004, Pages 5003-5012

  Baveja, J K ^a   Willcox, M D P ^a   Hume, E B H ^a   Kumar, N ^a   Odell, R ^a   Poole Warren, L A ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Anti bacterial; Bacterial adhesion; Biofilm; Biomaterials; Surface modification

Indexed keywords

ANTIBIOTICS; BIOFILMS; COLORIMETRIC ANALYSIS; EPIDEMIOLOGY; HYDROPHOBICITY; RADIOACTIVITY; SURFACE ROUGHNESS;

ANTI-BACTERIAL COATINGS; INFECTION; STAPHYOCOCCUS EPIDERMIS; VIRULENCE FACTOR;

BIOMATERIALS;

3 (1' BROMOHEXYL) 5 DIBROMOMETHYLENE 2(5H) FURANONE; BIOMATERIAL; FURANONE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIUM ADHERENCE; BACTERIUM ISOLATE; COLORIMETRY; CONTROLLED STUDY; DEVICE; DEVICE INFECTION; HYDROPHOBICITY; MATERIAL COATING; NONHUMAN; PRIORITY JOURNAL; RADIOACTIVITY; REDUCTION; STAPHYLOCOCCUS EPIDERMIDIS; SURFACE PROPERTY;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL ADHESION; BIOCOMPATIBLE MATERIALS; BIOFILMS; CELL ADHESION; CELL LINE; CELL PROLIFERATION; ETHANOL; FURANS; MATERIALS TESTING; MICE; MICROSCOPY, ATOMIC FORCE; MICROSCOPY, ELECTRON, SCANNING; MODELS, CHEMICAL; POLYMERS; SILICON; SPECTROMETRY, X-RAY EMISSION; STAPHYLOCOCCUS EPIDERMIDIS; STRESS, MECHANICAL; SURFACE PROPERTIES; TENSILE STRENGTH; TIME FACTORS;

BACTERIA (MICROORGANISMS); STAPHYLOCOCCUS; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 1942470982     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2004.02.051     Document Type: Article

References (53)

1. Christensen GD, Baldassarri L, Simpson WA. Colonisation of medical devices by coagulase-negative staphylococci. In: Bisno AL, Waldovogel FA, editors. Infections associated with indwelling medical devices, 2nd ed. Washington DC 20005: American Society for Microbiology; 1994.
2. Rupp M.E., Archer G.D. Coagulase-negative staphylococci. pathogens associated with medical progress Clin Infect Dis. 19:1994;231-245.
3. Peters G., Locci R., Pulverer G. Adherence and growth of coagulase-negative staphylococci on surfaces of intravenous catheters. J Infect Dis. 146:1982;479-482.
4. Franson T.R., Sheth N.K., Rose H.D., Sohnle P.G. Scanning electron microscopy of bacteria adherent to intravascular catheters. J Clin Microbiol. 20:1984;500-505.
5. Gray E.D., Peters G., Verstegen M., Regelmann W.E. Effect of extracellular slime substance from Staphylococcus epidermidis on human cellular immune response. Lancet. 18:1984;365-367.
6. Johnson G.M., Lee D.A., Regelmann W.E., Gray E.D., Peters G., Quie P.G. Interference with granulocyte function by Staphylococcus epidermidis slime. Infect Immun. 54:1986;13-20.
7. Duguid I.G., Evans E., Brown M.R., Gilbert P. Effect of biofilm culture upon the susceptibility of Staphylococcus epidermidis to tobramycin. J Antimicrob Chemother. 30:1992;803-810.
8. Bridgett M.J., Davies M.C., Denyer S.P., Eldridge P.R. In vitro assessment of bacterial adhesion to hydromer-coated cerebrospinal fluid shunts. Biomaterials. 14:1993;184-188.
9. Maki D.G., Cobb L., Garman J.K., Shapiro J.M., Ringer M., Helgerson R.B. An attachable silver-impregnated cuff for prevention of infection with central venous catheters. a prospective randomized multicenter trial Am J Med. 85:1988;307-314.
10. Raad I. Intravascular-catheter-related infections. Lancet. 351:1998;893-898.
11. Raad I., Darouiche R.O., Hachem R., Sacilowski M., Bodey G.P. Antibiotics and prevention of microbial colonization of catheters. Antimicrob Agents Chemother. 39:1995;2397-2400.
12. Schierholz J.M., Steinhauser H., Rump A.F., Berkels R., Pulverer G. Controlled release of antibiotics from biomedical polyurethanes. morphological and structural features Biomaterials. 18:1997;839-844.
13. Lelievre H., Lina G., Jones M.E., Olive C., Forey F., Roussel-Delvallez M., Nicolas-Chanoine M.H., Bebear C.M., Jarlier V.et al. Emergence and spread in French hospitals of methicillin-resistant Staphylococcus aureus with increasing susceptibility to gentamicin and other antibiotics. J Clin Microbiol. 37:1999;3452-3457.
14. Kjelleberg S, Steinberg PD, Holmstrom C, Back A. Inhibition of gram positive bacteria. Patent No. PCT/AU99/00284, 1999.
15. Holmstrom C, Kjelleberg S. Microbial inhibitory compositions. Patent No. PCT/AU01/00295, 2001.
16. Kozminykh V.O., Igidov N.M., Kozminykh E.N., Aliev Z.G. Reactions of 5-aryl-furan-2,3-diones with acylmethylenetriphenylphosphoranes. synthesis and biological activity of 3(2 H)-furanone derivatives Pharmazie. 48:1993;99-106.
17. Gein V.L., Gein L.F., Bezmaternykh E.N., Voronina E.V. Synthesis and antimicrobial activity of 4-aroyl-3-hydroxy-2,5-dihyrofuran-2-ones and their derivatives. Pharm Chem J. 34:2000;254-256.
18. Khan M.S., Husain A. Syntheses and reactions of some new 2-arylidene-4-(biphenyl-4-yl)-but-3-en-4-olides with a study of their biological activity. Pharmazie. 57:2002;448-452.
19. Levy L.M., Cabrera G.M., Wright J.E., Seldes A.M. 5H-furan-2-ones from fungal cultures of Aporpium caryae. Phytochemistry. 62:2003;239-243.
20. Ren D., Sims J.J., Wood T.K. Inhibition of biofilm formation and swarming of Bacillus subtilis by (5Z)-4-bromo-5-(bromomethylene)-3-butyl-2(5H)-furanone. Lett Appl Microbiol. 34:2002;293-299.
21. Darouiche R.O. Device-associated infections. a macroproblem that starts with microadherence Clin Infect Dis. 33:2001;1567-1572.
22. Christensen G.D., Simpson W.A., Younger J.J., Baddour L.M., Barrett F.F., Melton D.M., Beachey E.H. Adherence of coagulase-negative staphylococci to plastic tissue culture plates. a quantitative model for the adherence of staphylococci to medical devices J Clin Microbiol. 22:1985;996-1006.
23. Tsai C.L., Schurman D.J., Smith R.L. Quantitation of glycocalyx production in coagulase-negative Staphylococcus. J Orthop Res. 6:1988;666-670.
24. Zar J.H. Biostatistical analysis. 4th ed:1999;Prentice-Hall, Upper Saddle River, NJ.
25. Quinn G.P., Keough M.J. Experimental design and data analysis for biologists. 2002;Cambridge University Press, Cambridge.
26. Gottenbos B., van der Mei H.C., Busscher H.J. Initial adhesion and surface growth of Staphylococcus epidermidis and Pseudomonas aeruginosa on biomedical polymers. J Biomed Mater Res. 50:2000;208-214.
27. Arciola C.R., Cenni E., Caramazza R., Pizzoferrato A. Seven surgical silicones retain Staphylococcus aureus differently in vitro. Biomaterials. 16:1995;681-684.
28. Ludwicka A., Jansen B., Wadstrom T., Pulverer G. Attachment of staphylococci to various synthetic polymers. Zentralbl Bakteriol Mikrobiol Hyg [A]. 256:1984;479-489.
29. Sheth N.K., Rose H.D., Franson T.R., Buckmire F.L., Sohnle P.G. In vitro quantitative adherence of bacteria to intravascular catheters. J Surg Res. 34:1983;213-218.
30. An Y.H., Friedman R.J. Concise review of mechanisms of bacterial adhesion to biomaterial surfaces. J Biomed Mater Res. 43:1998;338-348.
31. John S.F., Derrick M.R., Jacob A.E., Handley P.S. The combined effects of plasma and hydrogel coating on adhesion of Staphylococcus epidermidis and Staphylococcus aureus to polyurethane catheters. FEMS Microbiol Lett. 144:1996;241-247.
32. Verheyen C.C., Dhert W.J., de Blieck-Hogervorst J.M., van der Reijden T.J., Petit P.L., de Groot K. Adherence to a metal, polymer and composite by Staphylococcus aureus and Staphylococcus epidermidis. Biomaterials. 14:1993;383-391.
33. Galliani S., Cremieux A., van der Auwera P., Viot M. Influence of strain, biomaterial, proteins, and oncostatic chemotherapy on Staphylococcus epidermidis adhesion to intravascular catheters in vitro. J Lab Clin Med. 127:1996;71-80.
34. Drake D.R., Paul J., Keller J.C. Primary bacterial colonization of implant surfaces. Int J Oral Maxillofac Implants. 14:1999;226-232.
35. Kristinsson K.G. Adherence of staphylococci to intravascular catheters. J Med Microbiol. 28:1989;249-257.
36. Espersen F., Wurr M., Corneliussen L., Hog A.L., Rosdahl V.T., Frimodt-Moller N., Skinhoj P. Attachment of staphylococci to different plastic tubes in vitro. J Med Microbiol. 40:1994;37-42.
37. Karakecili A.G., Gumusderelioglu M. Comparison of bacterial and tissue cell initial adhesion on hydrophilic/hydrophobic biomaterials. J Biomater Sci Polym Ed. 13:2002;185-196.
38. Tebbs S.E., Sawyer A., Elliott T.S. Influence of surface morphology on in vitro bacterial adherence to central venous catheters. Br J Anaesth. 72:1994;587-591.
39. Bellon J.M., N G.H., Jurado F., Carranza A., Bujan J. In vitro interaction of bacteria with polypropylene/ePTFE prostheses. Biomaterials. 22:2001;2021-2024.
40. Yorganci K., Krepel C., Weigelt J.A., Edmiston C.E. In vitro evaluation of the antibacterial activity of three different central venous catheters against gram-positive bacteria. Eur J Clin Microbiol Infect Dis. 21:2002;379-384.
41. Gottenbos B., van der Mei H.C., Klatter F., Nieuwenhuis P., Busscher H.J. In vitro and in vivo antimicrobial activity of covalently coupled quaternary ammonium silane coatings on silicone rubber. Biomaterials. 23:2002;1417-1423.
42. Maki D.G., Stolz S.M., Wheeler S., Mermel L.A. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic- impregnated catheter. A randomized, controlled trial. Ann Intern Med. 127:1997;257-266.
43. Kockro R.A., Hampl J.A., Jansen B., Peters G., Scheihing M., Giacomelli R., Kunze S., Aschoff A. Use of scanning electron microscopy to investigate the prophylactic efficacy of rifampin-impregnated CSF shunt catheters. J Med Microbiol. 49:2000;441-450.
44. Anwar H., Strap J.L., Chen K., Costerton J.W. Dynamic interactions of biofilms of mucoid Pseudomonas aeruginosa with tobramycin and piperacillin. Antimicrob Agents Chemother. 36:1992;1208-1214.
45. Sauer K., Camper A.K., Ehrlich G.D., Costerton J.W., Davies D.G. Pseudomonas aeruginosa displays multiple phenotypes during development as a biofilm. J Bacteriol. 184:2002;1140-1154.
46. Givskov M., de Nys R., Manefield M., Gram L., Maximilien R., Eberl L., Molin S., Steinberg P.D., Kjelleberg S. Eukaryotic interference with homoserine lactone-mediated prokaryotic signalling. J Bacteriol. 178:1996;6618-6622.
47. Gram L., de Nys R., Maximilien R., Givskov M., Steinberg P.D., Kjelleberg S. Inhibitory effects of secondary metabolites from the red alga Delisea pulchra on swarming motility of Proteus mirabilis. Appl Environ Microbiol. 62:1996;4284-4287.
48. Ren D., Sims J.J., Wood T.K. Inhibition of biofilm formation and swarming of Escherichia coli by (5Z)-4-bromo-5-(bromomethylene)-3-butyl-2(5H)-furanone. Environ Microbiol. 3:2001;731-736.
49. England D, Kjelleberg S. Inhibition of two-component signal transduction systems. Patent No. PCT/AU00/01553, 2001.
50. Kjelleberg S, Rice S, McDougald D. Regulation of bacterial virulence. Patent No. PCT/AU01/01621, 2002.
51. LaLonde R.T., Bu L., Henwood A., Fiumano J., Zhang L. Bromine-, chlorine-, and mixed halogen-substituted 4-methyl-2(5H)-furanones. synthesis and mutagenic effects of halogen and hydroxyl group replacements Chem Res Toxicol. 10:1997;1427-1436.
52. Janecki T., Blaszczyk E., Studzian K., Rozalski M., Krajewska U., Janecka A. New stereocontrolled synthesis and biological evaluation of 5-(1′-hydroxyalkyl)-3-methylidenetetrahydro-2-furanones as potential cytotoxic agents. J Med Chem. 45:2002;1142-1145.
53. Kim Y., Nam N.H., You Y.J., Ahn B.Z. Synthesis and cytotoxicity of 3,4-diaryl-2(5H)-furanones. Bioorg Med Chem Lett. 12:2002;719-722.